Detalles de la búsqueda
1.
Antidepressant deprescribing: State of the art and recommendations-A literature overview.
Eur J Clin Pharmacol;
80(3): 417-433, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38189859
2.
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.
Eur J Clin Pharmacol;
80(4): 519-527, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38244052
3.
A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy.
J Oncol Pharm Pract;
: 10781552241242096, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533561
4.
Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario.
Hosp Pharm;
59(2): 165-172, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38450361
5.
Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016.
J Oncol Pharm Pract;
29(1): 83-87, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34693799
6.
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
J Oncol Pharm Pract;
29(8): 1806-1815, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903919
7.
Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature.
Br J Clin Pharmacol;
88(5): 1999-2018, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34784654
8.
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
J Oncol Pharm Pract;
28(4): 870-883, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33847190
9.
Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting.
J Oncol Pharm Pract;
28(1): 24-30, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33349148
10.
Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials.
Eur J Clin Pharmacol;
76(6): 843-850, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125472
11.
Dosage adjustments in pivotal clinical trials with oral targeted therapies in solid tumors conducted in Europe.
Eur J Clin Pharmacol;
75(5): 697-706, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30617511
12.
Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia.
J Oncol Pharm Pract;
25(5): 1035-1041, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29460706
13.
Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
Acta Haematol;
136(1): 45-51, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160310
14.
Real-World Effectiveness of Calcitonin Gene-Related Peptide-Binding Monoclonal Antibodies for Migraine Prevention: A Systematic Review.
Can J Hosp Pharm;
77(1): e3382, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38204506
15.
Adherence, persistence and treatment switching in psoriasis.
Immunotherapy;
2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38651935
16.
Safety and Effectiveness of Multiple Switching Between Originators and Biosimilars: Literature Review and Status Report on Interchangeability.
Ther Innov Regul Sci;
57(2): 352-364, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36322326
17.
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs.
Eur J Hosp Pharm;
30(6): 328-332, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058307
18.
Time to treatment discontinuation in first-line non-small cell lung carcinoma: an overview.
Curr Med Res Opin;
39(12): 1603-1612, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36932463
19.
[Anti-CGRP monoclonal antibodies for the preventive treatment of migraine: a cost-effectiveness analysis in the Italian scenario.] / Anticorpi monoclonali anti-CGRP per il trattamento preventivo degli attacchi di emicrania: un'analisi costo-efficacia nello scenario italiano.
Recenti Prog Med;
114(3): 157-162, 2023 03.
Artículo
en Italiano
| MEDLINE | ID: mdl-36815419
20.
[Clinical trials approved by Aifa for Covid-19: report of the main results to fill the unmet medical need.] / Le sperimentazioni cliniche approvate dall'Aifa per Covid-19: report dei risultati principali per colmare l'unmet medical need.
Recenti Prog Med;
114(11): 669-674, 2023 11.
Artículo
en Italiano
| MEDLINE | ID: mdl-37902541